Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Peleg

Showing results (51-60 of 271) with videos related to

Pageof 28
Sort By:
Expert Review of Anti-Infective Therapy|August 22, 2020
Antimicrobial pharmacokinetics and preclinical <i>in vitro</i> models to support optimized treatment approaches for uncomplicated lower urinary tract infectionsIain J Abbott, Jason A Roberts, Joseph Meletiadis, et al.
Expert Review of Anti-Infective Therapy|April 9, 2015
Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesisCarina Dexter, Gerald L Murray, Ian T Paulsen, et al.
Plos Pathogens|June 3, 2016
Anti-infective Surface Coatings: Design and Therapeutic Promise against Device-Associated InfectionsBryan R Coad, Hans J Griesser, Anton Y Peleg, et al.
Infection Control and Hospital Epidemiology|June 30, 2006
Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in AustraliaAnton Y Peleg, Clare Franklin, Jan M Bell, et al.
Current Infectious Disease Reports|April 16, 2009
Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipientsAnton Y Peleg, Mary T Lasalvia, Eleftherios Mylonakis, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpointsIain J Abbott, Johan W Mouton, Anton Y Peleg, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2006
Common infections in diabetes: pathogenesis, management and relationship to glycaemic controlAnton Y Peleg, Thilak Weerarathna, James S McCarthy, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2023
The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care settingRekha Pai Mangalore, Trisha N Peel, Andrew A Udy, et al.
Molecular Biology and Evolution|February 15, 2023
Horizontal Gene Transfer, Fitness Costs and Mobility Shape the Spread of Antibiotic Resistance Genes into Experimental Populations of Acinetobacter BaylyiAysha L Sezmis, Laura C Woods, Anton Y Peleg, et al.
Australian Prescriber|February 16, 2019
Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problemsBradley J Gardiner, Andrew J Stewardson, Iain J Abbott, et al.
Pageof 28

Showing results (51-60 of 271) with videos related to

Sort By:
Pageof 28
Expert Review of Anti-Infective Therapy|August 22, 2020
Antimicrobial pharmacokinetics and preclinical <i>in vitro</i> models to support optimized treatment approaches for uncomplicated lower urinary tract infectionsIain J Abbott, Jason A Roberts, Joseph Meletiadis, et al.
Expert Review of Anti-Infective Therapy|April 9, 2015
Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesisCarina Dexter, Gerald L Murray, Ian T Paulsen, et al.
Plos Pathogens|June 3, 2016
Anti-infective Surface Coatings: Design and Therapeutic Promise against Device-Associated InfectionsBryan R Coad, Hans J Griesser, Anton Y Peleg, et al.
Infection Control and Hospital Epidemiology|June 30, 2006
Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in AustraliaAnton Y Peleg, Clare Franklin, Jan M Bell, et al.
Current Infectious Disease Reports|April 16, 2009
Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipientsAnton Y Peleg, Mary T Lasalvia, Eleftherios Mylonakis, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpointsIain J Abbott, Johan W Mouton, Anton Y Peleg, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2006
Common infections in diabetes: pathogenesis, management and relationship to glycaemic controlAnton Y Peleg, Thilak Weerarathna, James S McCarthy, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2023
The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care settingRekha Pai Mangalore, Trisha N Peel, Andrew A Udy, et al.
Molecular Biology and Evolution|February 15, 2023
Horizontal Gene Transfer, Fitness Costs and Mobility Shape the Spread of Antibiotic Resistance Genes into Experimental Populations of Acinetobacter BaylyiAysha L Sezmis, Laura C Woods, Anton Y Peleg, et al.
Australian Prescriber|February 16, 2019
Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problemsBradley J Gardiner, Andrew J Stewardson, Iain J Abbott, et al.
Pageof 28